BioSpace News Archive

Policy

BioPharmX Announces Patent Award, Expanding Protection for Innovations in Solid Dosage Forms

New patent protects improvements in oral drug delivery

August 9, 2018
·
3 min read
New Mallinckrodt Data Analysis Shows Limited Use Of Opioid-Free Analgesia, Underutilization In Some Patients More Prone To Opioid-Related Adverse Events

“Predictors of Opioid-Free Analgesia for Management of Acute Post-Surgical Pain in the U.S.” Finds Patients Most Likely to Receive Opioid-Free Analgesia Were Older or Had Neurological Disorders, Diabetes or Psychosis

August 9, 2018
·
6 min read
BioMidwest

Easterseals Assistive Technology Helps Promote Independence With $230,000 In Grants From The Comcast Foundation

This fund supports technology programs and services that benefit children and adults, including veterans, living with disabilities.

August 9, 2018
·
7 min read
Business

Sierra Oncology Reports Second Quarter Results

SRA737 Monotherapy trial prioritized for ovarian cancer; targeting enrollment of 65 patients with preliminary data anticipated in H1 2019

August 9, 2018
·
16 min read
Deals

OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company

Transaction to Advance Millendo’s Compelling Pipeline of Late-Stage Programs for Orphan Endocrine Diseases Including Prader-Willi Syndrome

August 9, 2018
·
13 min read
Business

Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Phase 2b Results for Topical Ocular Reproxalap in Dry Eye Disease Expected in Late Third Quarter or Early Fourth Quarter 2018

August 9, 2018
·
18 min read
Biotech Bay

Another Global Life-science Company Selected Cloud-based ValGenesis VLMS Solution to Manage Corporate Validation Process

ValGenesis, Inc. is pleased to announce that a global Life Science company with integrated services and product offering has chosen ValGenesis Validation Lifecycle Management System to manage their corporate validation lifecycle process in a 100% paperless mode.

August 9, 2018
·
2 min read
Business

Fibrocell Reports Second Quarter 2018 Financial Results and Recent HighlightsCompany to Host Conference Call and Webcast Today at 8:30 a.m. EDT

Fibrocell Science, Inc. reported financial results for the second quarter ended June 30, 2018 and recent operational highlights. Fibrocell will host a conference call and webcast today at 8:30 a.m. EDT.

August 9, 2018
·
12 min read
Business

DarioHealth Reports Second Quarter 2018 Results

Record Q2 2018 revenue of $2.06 million marks 70% growth year over year

August 9, 2018
·
20 min read
Business

Kelyniam Global Releases Financials Through June 30, 2018

Revenue increased 45% over the same period last year, growing to $1,118,512

August 9, 2018
·
2 min read